A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of ...

Medicus Pharma Ltd. (Nasdaq: MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets. The Company is ...

A powerful new treatment could soon help men whose prostate cancer returns after surgery or radiation. A large study shows ...

Health experts from the University of Exeter have played a key role in the shift, after conducting an economic evaluation of ...

The lifetime risk of Malaysian men developing cancer has increased from one in ten to one in eight, with colorectal, lung and ...

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between ...

A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and ...

Dr. Joshua Sabai spoke with Dr. Chandler Park about the latest advances in kidney cancer, highlighting clinical trials that are shaping care for patients.

A prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, ...

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

This study, while documenting ways that prostate cancer becomes resistant to treatment, shows the dedication and resourcefulness of this patient’s Hopkins oncology team, who never gave up. Sena and ...